Literature DB >> 974315

Depression by morphine of excitatory junction potentials in the vas deferens of the mouse.

G Henderson, R A North.   

Abstract

1 Intracellular recordings were made from smooth muscle cells of the mouse vas deferens. Excitatory junction potentials (e.j.ps) were evoked by stimulation of the intramural nerves. 2 Normorphine (50 nM-5muM) depressed the amplitude of the e.j.p. The ED50 was 430 nM. The latency of the e.j.p. and the resting membrane potential of the smooth muscle cells were unaffected by normorphine. 3 The depression of the e.j.p. by narcotic analgesic drugs was stereospecific. 4 Naloxone (100 nM) completely reversed the depression of the e.j.p. produced by normorphine (1 muM). Naloxone (100 nM) alone did not alter the amplitude of the e.j.p. 5 Normorphine (1 muM) did not prevent the depolarization of the smooth muscle cells produced by exogenous noradrenaline (10 muM). 6 It is concluded that narcotic analgesic drugs act directly upon the transmitter release sites to reduce the amount of noradrenaline liberated by each nerve impulse.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 974315      PMCID: PMC1667275     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  28 in total

1.  Proceedings: Is morphine inhibition to the twitch response of the mouse vas deferens mediated via noradrenaline?

Authors:  D A Jenkins; I Marshall; P A Nasmyth
Journal:  Br J Pharmacol       Date:  1975-10       Impact factor: 8.739

2.  Purification and properties of enkephalin - the possible endogenous ligand for the morphine receptor.

Authors:  J Hughes; T Smith; B Morgan; L Fothergill
Journal:  Life Sci       Date:  1975-06-15       Impact factor: 5.037

3.  Action of morphine on guinea-pig myenteric plexus and mouse vas deferens studied by intracellular recording.

Authors:  R A North; G Henderson
Journal:  Life Sci       Date:  1975-07-01       Impact factor: 5.037

4.  An electrophysiological analysis of the effects of reserpine on adrenergic neuromuscular transmission.

Authors:  M R Bennett; J Middleton
Journal:  Br J Pharmacol       Date:  1975-09       Impact factor: 8.739

5.  The effects of morphine on the release of noradrenaline from the cat isolated nictitating membrane and the guinea-pig ileum myenteric plexus-longitudinal muscle preparation.

Authors:  G Henderson; J Hughes; H W Kosterlitz
Journal:  Br J Pharmacol       Date:  1975-04       Impact factor: 8.739

6.  A new example of a morphine-sensitive neuro-effector junction: adrenergic transmission in the mouse vas deferens.

Authors:  G Henderson; J Hughes; H W Kosterlitz
Journal:  Br J Pharmacol       Date:  1972-12       Impact factor: 8.739

7.  Terminal axons ensheathed in smooth muscle cells of the vas deferens.

Authors:  J B Furness; T Iwayama
Journal:  Z Zellforsch Mikrosk Anat       Date:  1971

8.  A comparative study of spike potentials in response to nerve stimulation in the vas deferens of the mouse, rat and guinea-pig.

Authors:  J B Furness; G Burnstock
Journal:  Comp Biochem Physiol       Date:  1969-10-15

9.  Uptake of noradrenaline by adrenergic nerves, smooth muscle and connective tissue in isolated perfused arteries and its correlation with the vasoconstrictor response.

Authors:  O V Avakian; J S Gillespie
Journal:  Br J Pharmacol Chemother       Date:  1968-01

10.  Effect of morphine on adrenergic transmission in the mouse vas deferens. Assessment of agonist and antogonist potencies of narcotic analgesics.

Authors:  J Hughes; H W Kosterlitz; F M Leslie
Journal:  Br J Pharmacol       Date:  1975-03       Impact factor: 8.739

View more
  14 in total

1.  Enkephalins increase cyclic adenosine monophosphate content, calcium uptake, and contractile state in cultured chick embryo heart cells.

Authors:  S Laurent; J D Marsh; T W Smith
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

2.  Interactions among the effects of normorphine, calcium and magnesium on transmitter release in the mouse vas deferens.

Authors:  J D Milner; R A North; L V Vitek
Journal:  Br J Pharmacol       Date:  1982-05       Impact factor: 8.739

3.  Differential effect of stimulation strength in mouse vas deferens on inhibition of neuroeffector transmission by receptor type selective opioids.

Authors:  D Ramme; P Illes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-01       Impact factor: 3.000

4.  Effects of divalent cations and normorphine on spontaneous excitatory junction potentials in the mouse vas deferens.

Authors:  P Illes; R A North
Journal:  Br J Pharmacol       Date:  1982-04       Impact factor: 8.739

5.  An electrophysiological study of presynaptic alpha-adrenoceptors in the vas deferens of the mouse.

Authors:  P Illes; K Starke
Journal:  Br J Pharmacol       Date:  1983-02       Impact factor: 8.739

6.  Inhibition of neuroeffector transmission by morphine in the vas deferens of naive and morphine-treated mice.

Authors:  P Illes; R Schulz
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

7.  A study of the role of cyclic adenosine 3',5'-monophosphate in the depression by opiates and opioid peptides of excitatory junction potentials in the mouse vas deferens.

Authors:  R A North; L V Vitek
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

8.  An electrophysiological analysis of the effects of morphine on the calcium dependence of neuromuscular transmission in the mouse vas deferens.

Authors:  M R Bennett; N A Lavidis
Journal:  Br J Pharmacol       Date:  1980-06       Impact factor: 8.739

9.  Immunohistochemical localization of Met5-enkephalin-Arg6-Gly7-Leu8 in the female genital organs and in the paracervical ganglion of the pig.

Authors:  O Häppölä; M Lakomy; N Yanaihara
Journal:  Histochemistry       Date:  1990

10.  The effect of chronic morphine treatment of excitatory junction potentials in the mouse vas deferens.

Authors:  R A North; L V Vitek
Journal:  Br J Pharmacol       Date:  1980-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.